Health
Roche's Lung Cancer Drug Advances
Roche’s KRAS drug divarasib shows promising results in treating lung cancer. The drug is a highlight of this year’s ESMO conference.
Coverage timeline — 1 article
STAT News
One of the more impressive data sets at this year’s ESMO came from a Roche study of its drug divarasib, which treats lung cancer.
2026-10-26 23:17 UTC